# The Women's Screening and Self-Testing Program (PROMETA) Study

> **NCT06810739** · NA · NOT_YET_RECRUITING · sponsor: **Tulane University** · enrollment: 8445 (estimated)

## Conditions studied

- Human Papilloma Virus Related Cervical Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** HPV DNA testing be self-collected vaginal swab

## Key facts

- **NCT ID:** NCT06810739
- **Lead sponsor:** Tulane University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-08-31
- **Target enrollment:** 8445 (ESTIMATED)
- **Last updated:** 2025-12-17

## Collaborators

- National Cancer Institute (NCI)
- National Institutes of Health (NIH)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06810739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06810739, "The Women's Screening and Self-Testing Program (PROMETA) Study". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT06810739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*